The Impact of Patient Characteristics on Tumor Cell Program Death Ligand 1 Expression in Patients With NCSLC

J Thorac Oncol. 2019 Sep;14(9):e211. doi: 10.1016/j.jtho.2019.05.034.

Authors

Zhijie Xu¹, Xiang Wang², Xi Chen², Zhicheng Gong², Yuanliang Yan³

Affiliations

¹ Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
² Department of Pharmacy, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.
³ Department of Pharmacy, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China. Electronic address: yanyuanliang@csu.edu.cn.

PMID: 31445743
DOI: 10.1016/j.jtho.2019.05.034

No abstract available

Publication types

Letter
Comment

MeSH terms

Adenocarcinoma*
Apoptosis
B7-H1 Antigen
Carcinoma, Non-Small-Cell Lung*
Humans
Lung Neoplasms*

Substances

B7-H1 Antigen